A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...
13h
MarketBeat on MSNGLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss TrendsThe supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...
WEIGHT loss jabs slash alcohol cravings and can curb dangerous binge drinking, new research suggests. The active drug ...
Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued ...
Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...
10h
Daily Express US on MSNOzempic and Zepbound linked to rare eye conditions that could cause blindnessA new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsTim Power - Head of IRChris Viehbacher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results